ImmunityBio, Inc.

IBRX ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Profit History

Revenue Operating Income Net Income

Period	Revenue	Operating Income	Net Income
Mar 2014	$286.0K	$-826.0K	$-1.1M
Jun 2014	$124.0K	$-1.2M	$-1.4M
Sep 2014	$133.0K	$-919.0K	$-918.0K
Dec 2014	$98.0K	$-2.6M	$-2.8M
Mar 2015	$120.0K	$-32.1M	$-32.8M
Jun 2015	$91.0K	$-130.4M	$-130.9M
Sep 2015	$10.0K	$-46.5M	$-46.3M
Dec 2015	$15.0K	$-29.9M	$-26.8M
Mar 2016	$6.0K	$-31.6M	$-30.7M
Jun 2016	$12.0K	$-35.0M	$-34.0M
Sep 2016	$12.0K	$-32.8M	$-31.9M
Dec 2016	$14.0K	$-25.1M	$-24.2M
Mar 2017	$11.0K	$-25.5M	$-24.5M
Jun 2017	$14.0K	$-23.8M	$-23.5M
Sep 2017	$8.0K	$-24.4M	$-24.0M
Dec 2017	$12.0K	$-25.4M	$-24.5M
Mar 2018	$5.0K	$-28.3M	$-27.5M
Jun 2018	$4.0K	$-28.3M	$-27.7M
Sep 2018	$31.0K	$-24.1M	$-23.6M
Dec 2018	$7.0K	$-17.7M	$-17.3M
Mar 2019	$5.0K	$-18.3M	$-17.9M
Jun 2019	$17.0K	$-17.3M	$-16.7M
Sep 2019	$12.0K	$-16.1M	$-15.6M
Dec 2019	$9.0K	$-16.1M	$-15.6M
Mar 2020	$165.0K	$-36.7M	$-37.0M
Jun 2020	$436.0K	$-50.9M	$-51.4M
Sep 2020	$151.0K	$-65.9M	$-65.6M
Dec 2020	$21.0K	$-30.9M	$-32.1M
Mar 2021	$139.0K	$-86.3M	$-79.6M
Jun 2021	$339.0K	$-85.9M	$-88.3M
Sep 2021	$66.0K	$-78.8M	$-87.6M
Dec 2021	$390.0K	$-79.3M	$-91.3M
Mar 2022	$14.0K	$-96.0M	$-102.8M
Jun 2022	$35.0K	$-79.6M	$-94.6M
Sep 2022	$118.0K	$-90.8M	$-110.9M
Dec 2022	$73.0K	$-84.9M	$-108.2M
Mar 2023	$360.0K	$-111.6M	$-116.3M
Jun 2023	$41.0K	$-85.1M	$-137.9M
Sep 2023	$82.0K	$-80.1M	$-95.6M
Dec 2023	$139.0K	$-85.4M	$-233.4M
Mar 2024	$40.0K	$-95.2M	$-134.1M
Jun 2024	$1.0M	$-99.3M	$-134.6M
Sep 2024	$6.1M	$-80.3M	$-85.7M
Dec 2024	$7.6M	$-69.4M	$-59.2M
Mar 2025	$16.5M	$-64.4M	$-129.6M
Jun 2025	$26.4M	$-71.3M	$-92.6M
Sep 2025	$32.1M	$-55.6M	$-67.3M
Dec 2025	$38.3M	$-64.7M	$-61.9M
Mar 2026	$44.2M	$-69.8M	$-632.8M
Jun 2026	$51.2M	$-61.7M	$-230.4M